Tweets
RheumNow’s expanded coverage of the #ACR2019 annual meeting is sponsored in part by Horizon Therapeutics. All content chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
What percentage of your SLE and RA patients receive HCQ above the 5mg/kg recommended by AAO? #ACR19 @rheumnow #Abstr #ACRBest
Jonathan Hausmann MD @hausmannMD ( View Tweet )
6 years 9 months ago
How do you taper steroids in RA?
I take a personalised approach i.e. I guess based on experience of similar pt situations & what I think the pt will tolerate.
Is it evidence-based? Not really.
Is there any evidence to guide it? Well...😐
@umichmedicine #ACR19 ABST0554 @RheumNow https://t.co/YFlvyYuBee
David Liew @drdavidliew ( View Tweet )
6 years 9 months ago
MTX and RTX significantly reduce immunogenicity it flu and pneumonia vaccines. When possible, time appropriately! @RheumNow @LCalabreseDO #ACR19 https://t.co/udmqkbLG64
Cassandra Calabrese @CCalabreseDO ( View Tweet )
6 years 9 months ago
@RheumNow #ACR19 https://t.co/fmLAr2X4y5
Olga Petryna @DrPetryna ( View Tweet )
6 years 9 months ago
Black vs White US data
2-3x incidence in black patients
Deaths 13yrs sooner with 2-3x higher mortality
#ACR19 @rheumnow Abst0805
Dr Irwin Lim @_connectedcare ( View Tweet )
6 years 9 months ago
By the way, how many of you use low dose aspirin routinely in SLE pregnancies?
#ACR19 @rheumnow
Dr Irwin Lim @_connectedcare ( View Tweet )
6 years 9 months ago
What imaging do you use in gout? Check out the updated PANLAR recommendations abst#301 @RheumNow #ACR19
Dr. Rachel Tate @uptoTate ( View Tweet )
6 years 9 months ago
#RA study shows that from 2014 to 2018, the number of malignant tumors that could be treated with immune checkpoint inhibitors has grown from 0 to 7%. Knowledge of ICI immune related adverse events is essential for rheumatologists https://t.co/bwRYRBl4PE
Links:
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
Retrospective study of 102 RA patients interstitial lung dz, and 52% had progressive fibrosing-ILD; these were associated with increased mortality. Predictors of mortality were DLco and high titres https://t.co/Ydd9xAhsag IgM rheumatoid factor
Links:
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended marketing authorization for upadacitinib (Rinvoq) for the treatment of rheumatoid arthritis #RA. https://t.co/xnun9oiO9q
Links:
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
THe European Medicines Agency committee announced a positive opinion recommending romosozumab for the treatment of severe osteoporosis in postmenopausal women at high Fracture risk for fracture w/ no hx of MI/CVA https://t.co/sr7iPaSngj
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
RheumNow Podcast is up! The week in review - Watch it here>> https://t.co/c0EPyvKNWD or listen to the podcast in your car (Android Auto, Apple Car play) or here>> https://t.co/xZWQTszGn9
Links:
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
RheumNow Podcast is up! The week in review - on statins, Comorbidities, ANA specificity, APL Ab effects, PsA surgery & more. Watch it here>> https://t.co/c0EPyvKNWD or listen to the podcast in your car (Android Auto, Apple Car play) or here>> https://t.co/xZWQTszGn9
Links:
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
Risk of uveitis in JIA - study 2294 JIA pts in the UK JIA registries finds that uveitis occured in 27/943 MTX, 16/1047, and only 1 of 304 adalimumab/infliximab Rx pts. No difference w/ MTX & etanercept, but much less with adalimumab https://t.co/rO13LznMmm
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
